« Previous
Next »
Nanomedicine: Nanotechnology, Biology and Medicine
Volume 6, Issue 1
, Pages 93-102
, February 2010
Toxic and teratogenic silica nanowires in developing vertebrate embryos
References
- . In vivo imaging of 64Cu-labeled polymer nanoparticles targeted to the lung endothelium. J Nucl Med. 2008;49(1):103–111
- . Functional dye-doped silica nanoparticles for bioimaging, diagnostics and therapeutics. Food Bioprod Process. 2005;83(2):136–140
- . Nanostructured materials for applications in drug delivery and tissue engineering. J Biomater Sci. 2007;18(3):241–268
- Fibronectin bonding to nanowires and their internalization by epithelial cells. J Biomed Nanotech. 2006;2(1):1–6
- Nanowire-based delivery of Escherichia coli O157 Shiga toxin 1 A subunit into human and bovine cells. Nano Lett. 2007;7(9):2718–2723
- TAT conjugated, FITC doped silica nanoparticles for bioimaging applications. Chem Commun. 2004;2810–2811
- Cationic silica nanoparticles as gene carriers: synthesis, characterization and transfection efficiency in vitro and in vivo. J Nanosci Nanotech. 2004;4(7):876–881
- Near-infrared mesoporous silica nanoparticles for optical imaging: characterization and in vivo biodistribution. Adv Funct Mater. 2008;19(2):215–222
- . Nonviral gene delivery: thinking of silica. Gene Ther. 2006;13(7):585–586
- . Comparing study of the effect of nanosized silicon dioxide and microsized silicon dioxide on fibrogenesis in rats. Toxicol Ind Health. 2004;20:21–27
- . In vivo study of biodistribution and urinary excretion of surface-modified silica nanoparticles. Anal Chem. 2008;80(24):9597–9603
- Imaging breast cancer cells and tissues using peptide-labeled fluorescent silica nanoparticles. J Nanosci Nanotechnol. 2008;8(5):2483–2487
- . Nanosized bioceramic particles could function as efficient gene delivery vehicles with target specificity for the spleen. Gene Ther. 2007;14(10):828–835
- . Formation of nucleoplasmic protein aggregates impairs nuclear function in response to SiO2 nanoparticles. Exp Cell Res. 2005;305(1):51–62
- One-dimensional silica structures and their application to the biological sciences. In: Kumar C editors. Nanomaterials for the life sciences, Volume 2, Nanostructured oxides. Hoboken (NJ): John Wiley & Sons; 2009;p. 83–108
- A nonviral DNA delivery system based on surface modified silica-nanoparticles can efficiently transfect cells in vitro. Bioconjug Chem. 2000;11(6):926–932
- . A self-assembled, modular DNA delivery system mediated by silica nanoparticles. J Control Release. 2004;95(2):333–341
- Differential cytotoxicity exhibited by silica nanowires and nanoparticles. Nanotoxicology. 2008;2(1):1–8
- . In vitro toxicity of silica nanoparticles in human lung cancer cells. Toxicol Appl Pharmacol. 2006;217(3):252–259
- . Toxicity of luminescent silica nanoparticles to living cells. Chem Res Toxicol. 2007;20(8):1126–1133
- . Comparative study of cytotoxicity, oxidative stress and genotoxicity induced by four typical nanomaterials: the role of particle size, shape and composition. J Appl Toxicol. 2008;29(1):69–78
- . Effects of silicon nanowires on HepG2 cell adhesion and spreading. Chem Biochem. 2007;8(10):1115–1118
- Organically modified silica nanoparticles: a nonviral vector for in vivo gene delivery and expression in the brain. Proc Natl Acad Sci USA. 2005;102(32):11539–11544
- . Oxidative stress and pro-inflammatory responses induced by silica nanoparticles in vivo and in vitro. Toxicol Lett. 2009;184(1):18–25
- The potential risks of nanomaterials: a review carried out for ECETOC. Particle Fibre Toxicol. 2006;3(11):1–35
- . Holoprosencephaly in human embryos: epidemiologic studies of 150 cases. Teratology. 1977;16(3):261–272
- . Fullerene C60 exposure elicits an oxidative stress response in embryonic zebrafish. Toxicol Appl Pharmacol. 2007;229(1):44–55
- . Biodistribution and toxicity of nanomaterials in vivo: effects of composition, size, surface functionalization and route of exposure. NSTI-Nanotech. 2007;2:666–669
- . Quantification of fullerenes by LC/ESI-MS and its application to in vivo toxicity assays. Anal Chem. 2007;79(23):9091–9097
- Europium(III) complexes/silica hybrid nanospheres synthesized in microemulsion. J Nanosci Nanotechnol. 2008;8(3):1218–1220
- Fluorescent intensity-based differential counting of FITC-doped silica nanoparticles: applications of CD4+ T-cell detection in microchip-type flowcytometers. Proc SPIE. 2006;6416:641605
- . Development of novel dye-doped silica nanoparticles for biomarker application. J Biomed Opt. 2001;6(2):160–166
- . Stöber synthesis of monodispersed luminescent silica nanoparticles for bioanalytical assays. Langmuir. 2005;21(10):4277–4280
- . The zebrafish book: A guide for the laboratory use of the zebrafish (Danio rerio). 4th ed. Eugene (Ore): Oregon University of Oregon Press; 2000;
- . Sonic hedgehog, secreted by amacrine cells, acts as a short-range signal to direct differentiation and lamination in the zebrafish retina. Development (Cambridge, England). 2004;131(16):3849–3858
- . Effective targeted gene 'knockdown' in zebrafish. Nat Genet. 2000;26(2):216–220
- . Diethylstilbestrol induces fish oocyte maturation. Proc Natl Acad Sci USA. 2004;101(10):3686–3690
- . The vesicular integral protein-like gene is essential for development of a mechanosensory system in zebrafish. Dev Neurobiol. 2008;68(12):1391–1405
- . Hedgehog signalling controls zebrafish neural keel morphogenesis via its level-dependent effects on neurogenesis. Dev Dyn. 2006;235(4):978–997
- Patterning activities of vertebrate hedgehog proteins in the developing eye and brain. Curr Biol. 1995;5(8):944–955
- . Extraretinal and retinal hedgehog signaling sequentially regulate retinal differentiation in zebrafish. Dev Biol. 2003;258(2):349–363
- . Teratogenesis of holoprosencephaly. Am J Med Genet. 2002;109(1):1–15
- . Novel harmful effects of [60]fullerene on mouse embryos in vitro and in vivo. FEBS Lett. 1996;393(1):139–145
- Carbon nanotubes introduced into the abdominal cavity of mice show asbestos-like pathogenicity in a pilot study. Nat Nanotechnol. 2008;3(7):423–428
Dr. McIlroy is the Vice President of Research of GoNano Technologies, Inc. The current article has no relationship to GoNano. No conflict of interest was reported by the authors of this article.
This work was supported by the University of Idaho-BANTech Initiative and by NIH R01 EY012146 (D.L.S.).
PII: S1549-9634(09)00096-3
doi: 10.1016/j.nano.2009.05.003
© 2010 Elsevier Inc. All rights reserved.
« Previous
Next »
Nanomedicine: Nanotechnology, Biology and Medicine
Volume 6, Issue 1
, Pages 93-102
, February 2010
